jamunjar-logo
whatsapp
cartmembermenu
Search for
"test & packages"
"physiotherapy"
"heart"
"lungs"
"diabetes"
"kidney"
"liver"
"cancer"
"thyroid"
"bones"
"fever"
"vitamin"
"iron"
"HTN"

Urine Porphobilinogen

Kidney
image

Report in 192Hrs

image

At Home

nofastingrequire

No Fasting Required

Details

Detects porphobilinogen.

5,1807,400

30% OFF

Urine Porphobilinogen Test Information Guide

  • Why is it done?
    • Detects porphobilinogen, a precursor to heme synthesis that accumulates in acute porphyrias when heme production is disrupted
    • Diagnosing acute intermittent porphyria (AIP) and other acute hepatic porphyrias during acute attacks
    • Evaluating patients presenting with unexplained acute neurological symptoms, abdominal pain, psychiatric manifestations, or autonomic dysfunction
    • Screening at-risk family members of patients with confirmed acute porphyria
    • Monitoring disease activity and response to treatment in patients with known porphyria
    • Typically performed during acute episodes when symptoms are present; can also be done during remission to establish baseline levels
  • Normal Range
    • Normal Reference Range: Less than 2 mg/24 hours (or <9.4 µmol/24 hours in SI units)
    • Some laboratories use <1.5 mg/24 hours or <1.8 mg/24 hours depending on methodology
    • Units: mg/24 hours (milligrams per 24-hour collection) or µmol/24 hours (micromoles per 24-hour collection)
    • Negative Result: Absence of porphobilinogen (normal finding); suggests porphyria is unlikely
    • Positive Result: Elevated PBG levels (typically >2 mg/24 hours); indicates presence of acute porphyria or acute attack
    • Markedly Elevated: Levels significantly above 10 mg/24 hours strongly suggest active acute porphyria attack
  • Interpretation
    • Elevated PBG During Acute Attack: Strongly suggests acute intermittent porphyria (AIP), variegate porphyria (VP), or hereditary coproporphyria (HCP); clinical correlation with symptoms is essential
    • Persistent Elevation: May indicate ongoing acute phase or severe disease; requires further investigation with plasma porphobilinogen and plasma aminolevulinic acid (ALA) tests
    • Normal Results During Symptoms: Does not exclude porphyria in early phases; repeat testing may be necessary during acute exacerbation
    • Normal Results During Remission: Expected finding; confirms disease is in remission phase
    • False Positives May Occur: With pregnancy, birth control use, hormonal therapy, stress, fasting, certain infections, or menstrual cycle fluctuations
    • Factors Affecting Results: Improper urine collection, light exposure, contamination, delays in processing, certain medications (barbiturates, sulfonamides, estrogens), and metabolic stressors can influence levels
    • Best Timing for Testing: During acute attack (within 24-72 hours of symptom onset) when PBG levels peak for optimal diagnostic accuracy
  • Associated Organs
    • Primary Organ Systems: Nervous system, hepatic (liver), gastrointestinal system, and endocrine system; metabolic dysfunction affects multiple organ systems
    • Acute Intermittent Porphyria (AIP): Most common acute porphyria; presents with acute neurovisceral attacks including severe abdominal pain, psychiatric symptoms, neurological complications, autonomic instability
    • Variegate Porphyria (VP): Causes acute attacks similar to AIP plus photosensitivity with blistering skin lesions; increased cardiovascular complications
    • Hereditary Coproporphyria (HCP): Presents with acute neurovisceral attacks and photosensitivity; less common than AIP
    • Complications of Elevated PBG: Neurovisceral crisis, acute paralysis, respiratory failure requiring mechanical ventilation, cardiac arrhythmias, seizures, severe autonomic dysfunction
    • Chronic Manifestations: Hypertension, renal dysfunction, hepatic cirrhosis, neurological sequelae from recurrent attacks, increased risk of hepatocellular carcinoma
    • Associated Metabolic Disorders: Porphyrias result from enzyme deficiencies in heme synthesis pathway, primarily affecting liver (delta-aminolevulinic acid synthase regulation)
  • Follow-up Tests
    • Plasma Porphobilinogen (PBG) and Plasma Aminolevulinic Acid (ALA): Essential confirmatory tests; acute porphyria typically shows elevation of both plasma and urine PBG and ALA
    • Urine Delta-Aminolevulinic Acid (ALA): Complements PBG testing; typically elevated concurrently in acute attacks; helps differentiate porphyria type
    • Porphyrin Studies: Quantitative fecal coproporphyrin, urine coproporphyrin, and urine uroporphyrin; help identify specific porphyria type (VP shows elevated fecal coproporphyrin)
    • Genetic Testing: DNA sequencing for PBGD, PPOX, or CPOX gene mutations; confirms diagnosis and identifies carriers in family members
    • Acute Phase Labs: Electrolytes, glucose, liver function tests, renal function, magnesium to assess organ involvement during acute attack
    • Neurological Assessment: MRI, EMG, or nerve conduction studies if neurological complications suspected; EEG if seizures occur
    • Baseline and Monitoring Testing: Repeat PBG testing during remission (every 6-12 months) to establish baseline and monitor disease progression
    • Family Screening: First-degree relatives should undergo plasma PBG, plasma ALA, and genetic testing to identify asymptomatic carriers
  • Fasting Required?
    • Fasting: No, fasting is NOT required for urine porphobilinogen collection
    • 24-Hour Urine Collection: Standard collection method; patient should discard first morning void, then collect all urine for 24 hours including next morning void
    • Container Requirements: Use sterile container provided by laboratory; many contain preservatives (boric acid or acetic acid) to prevent bacterial overgrowth and preserve porphobilinogen
    • Light Protection: Keep urine collection away from direct sunlight and protect container from light exposure; store in refrigerator or cool location
    • Medications to Consider: Inform physician of all current medications; barbiturates, estrogens, sulfonamides, and other drugs may precipitate attacks and increase PBG levels
    • Stress Management: Avoid unnecessary stress, fasting, or extreme exercise before collection; these factors can trigger porphyria attacks and alter results
    • Hydration: Maintain normal fluid intake; excessive hydration or dehydration can affect urine concentration and test results
    • Specimen Processing: Transport specimen to laboratory promptly; most labs require processing within 2-4 hours of collection completion for optimal results

How our test process works!

customers
customers